AVEO News and Press, AVEO Pharmaceuticals Inc.

SEOUL, South Korea, Jan. 19, 2023 (GLOBE NEWSWIRE) -- LG Chem, Ltd. (“LG Chem”) (KOSPI: 051910) today announced that it has completed its previously announced acquisition of AVEO Oncology (“AVEO”), a commercial stage, oncology-focused biopharmaceutical company committe...

Aveo Oncology ( NASDAQ: AVEO ) shareholders have approved the company's proposed acquisition by LG Chem ( OTCPK:LGCLF ). In October 2022, LG Chem ( OTCPK:LGCLF ) proposed to acquire Aveo Oncology ( AVEO ) for $15/share in an all-cash transaction with an implied equity ...

BOSTON, Jan. 05, 2023 (GLOBE NEWSWIRE) -- AVEO Oncology (“AVEO”) (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer, announced that at a special meeting of stockholders ...

BOSTON, Jan. 03, 2023 (GLOBE NEWSWIRE) -- AVEO Oncology (“AVEO”) (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer, reminds all AVEO stockholders to vote before AVEO&#x...

AVEO Pharmaceuticals press release ( NASDAQ: AVEO ): Q3 GAAP EPS of -$0.09 beats by $0.08 . Revenue of $30.4M (+100.4% Y/Y) beats by $0.54M . At September 30, 2022, AVEO reported $77.4 million in cash, cash equivalents and marketable securities, as co...

– Total Q3 2022 Net Revenue of $30.4 million, including $30.2 million of FOTIVDA® (tivozanib) U.S. Net Product Revenue – – Announced entering a definitive agreement under which LG Chem will acquire AVEO for $15.00 per share in an all-cash tr...

Summary The macroeconomic factors create a highly favorable mergers and acquisition environment. Several interesting deals are being executed this month. As it's a strong buyers' market, you're likely to see more buyouts going toward year-end and next year. Axsome is an ideal ...

Summary Riding two powerful franchises (Iomab and Actimab), Actinium Pharmaceuticals is brewing a deep pipeline of therapeutics for multiple indications. There is also AWE Technology that is developed in collaboration with other biotech innovators. The best time to consider pi...

Summary As bargain opportunities are abound, big pharmaceuticals operators are sizing more deals for potential acquisitions. The Korea-based company (LG Chem) recently made an offer to acquire Aveo Oncology. Aveo adds greater oncology expertise to LG Chem as well as expands it...

NEW YORK, NY / ACCESSWIRE / October 19, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: AVEO Pharmaceuticals, Inc. (NASDA...